首页 > 最新文献

Endoscopy International Open最新文献

英文 中文
Optimal endoscopic resection method based on vertical margin distance for small rectal neuroendocrine tumors: Propensity score-matched study. 基于垂直切缘距离的直肠小神经内分泌肿瘤最佳内镜切除方法:倾向评分匹配研究。
IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-08-15 eCollection Date: 2025-01-01 DOI: 10.1055/a-2655-1320
Jianning Liu, Weihua Yu, Peng Liu, Hao Tian, Lihong Gan, Kaige Zhang, Hui Chen, Nian Fang

Background and study aims: Advanced endoscopic resection methods are recommended for removing rectal neuroendocrine tumors (NETs) < 10 mm, but there is no consensus on optimal endoscopic technique. This study aimed to determine whether endoscopic mucosal resection with ligation (EMR-L) is superior to endoscopic submucosal dissection (ESD) in terms of efficacy and safety, focusing on achieving adequate vertical margin distance.

Patients and methods: This dual-center cohort study included consecutive patients with rectal NETs ≤ 10 mm. Adequate vertical margins were exploratively defined as a margin distance exceeding 115 μm, the 25th percentile threshold. Propensity score matching (PSM) was applied to compare outcomes between EMR-L and ESD.

Results: The study included 204 rectal NETs from 186 patients, with 61 lesions in each group after PSM. Compared with ESD, the EMR-L group demonstrated a higher R0 resection rate (98.4% vs. 83.6%, P = 0.021), a greater proportion of adequate vertical margins (80.3% vs. 62.3%, P = 0.030), and a lower rate of positive vertical margins (1.6% vs. 13.1%, P = 0.041). Subgroup analysis indicated that lesions ≤ 5 mm without prior biopsy or central depression derived greater benefit from EMR-L. Furthermore, EMR-L was associated with significantly shorter procedure times (median 5.0 vs. 19 minutes) and a markedly lower overall complication rate (8.2% vs. 29.5%, P = 0.005), particularly perforation (3.3% vs. 16.4%, P = 0.028).

Conclusions: EMR-L outperforms ESD for small rectal NETs by achieving higher R0 and better vertical margins in shorter times, while minimizing risk of perforation.

背景与研究目的:对于< 10 mm的直肠神经内分泌肿瘤(NETs),建议采用先进的内镜切除方法,但对最佳内镜技术尚无共识。本研究旨在确定内镜下粘膜结扎切除术(EMR-L)是否优于内镜下粘膜剥离术(ESD)的有效性和安全性,重点关注是否能获得足够的垂直切缘距离。患者和方法:这项双中心队列研究包括直肠NETs≤10 mm的连续患者。适当的垂直边缘被探索性地定义为边缘距离超过115 μm,即第25个百分位阈值。倾向评分匹配(PSM)用于比较EMR-L和ESD的结果。结果:本研究纳入186例204例直肠NETs,每组经PSM后病变61个。与ESD组相比,EMR-L组的R0切除率更高(98.4%比83.6%,P = 0.021),垂直切缘充足的比例更高(80.3%比62.3%,P = 0.030),垂直切缘阳性的比例更低(1.6%比13.1%,P = 0.041)。亚组分析表明,病变≤5mm且没有事先活检或中枢性凹陷的患者从EMR-L中获益更大。此外,EMR-L显著缩短了手术时间(中位数5.0 vs 19分钟),显著降低了总并发症发生率(8.2% vs 29.5%, P = 0.005),尤其是穿孔(3.3% vs 16.4%, P = 0.028)。结论:EMR-L优于ESD,在更短的时间内获得更高的R0和更好的垂直切缘,同时最大限度地降低了穿孔的风险。
{"title":"Optimal endoscopic resection method based on vertical margin distance for small rectal neuroendocrine tumors: Propensity score-matched study.","authors":"Jianning Liu, Weihua Yu, Peng Liu, Hao Tian, Lihong Gan, Kaige Zhang, Hui Chen, Nian Fang","doi":"10.1055/a-2655-1320","DOIUrl":"10.1055/a-2655-1320","url":null,"abstract":"<p><strong>Background and study aims: </strong>Advanced endoscopic resection methods are recommended for removing rectal neuroendocrine tumors (NETs) < 10 mm, but there is no consensus on optimal endoscopic technique. This study aimed to determine whether endoscopic mucosal resection with ligation (EMR-L) is superior to endoscopic submucosal dissection (ESD) in terms of efficacy and safety, focusing on achieving adequate vertical margin distance.</p><p><strong>Patients and methods: </strong>This dual-center cohort study included consecutive patients with rectal NETs ≤ 10 mm. Adequate vertical margins were exploratively defined as a margin distance exceeding 115 μm, the 25th percentile threshold. Propensity score matching (PSM) was applied to compare outcomes between EMR-L and ESD.</p><p><strong>Results: </strong>The study included 204 rectal NETs from 186 patients, with 61 lesions in each group after PSM. Compared with ESD, the EMR-L group demonstrated a higher R0 resection rate (98.4% vs. 83.6%, <i>P</i> = 0.021), a greater proportion of adequate vertical margins (80.3% vs. 62.3%, <i>P</i> = 0.030), and a lower rate of positive vertical margins (1.6% vs. 13.1%, <i>P</i> = 0.041). Subgroup analysis indicated that lesions ≤ 5 mm without prior biopsy or central depression derived greater benefit from EMR-L. Furthermore, EMR-L was associated with significantly shorter procedure times (median 5.0 vs. 19 minutes) and a markedly lower overall complication rate (8.2% vs. 29.5%, <i>P</i> = 0.005), particularly perforation (3.3% vs. 16.4%, <i>P</i> = 0.028).</p><p><strong>Conclusions: </strong>EMR-L outperforms ESD for small rectal NETs by achieving higher R0 and better vertical margins in shorter times, while minimizing risk of perforation.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"13 ","pages":"a26551320"},"PeriodicalIF":2.3,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12371650/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144947364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic papillectomy of major papilla lesions: Single tertiary care center experience. 内窥镜乳头切除术的主要乳头病变:单一三级护理中心经验。
IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-08-14 eCollection Date: 2025-01-01 DOI: 10.1055/a-2663-6291
Gaurav Suryawanshi, Mohamed Abdallah, Guru Trikudanathan, Stuart K Amateau, Shawn Mallery, Martin Freeman, Nabeel Azeem

Background and study aims: Endoscopic papillectomy (EP) is an effective endoscopic modality for managing ampullary lesions. This study aimed to evaluate predictors for recurrence and adverse events (AEs) in patients who underwent EP for major papilla lesions.

Patients and methods: This was a retrospective analysis of all patients who underwent endoscopic snare papillectomy for a major papilla lesion between January 2006 and December 2021. We assessed multiple patient- and procedure-related variables to identify risk factors related to post-EP AEs and lesion recurrence using both univariate and multivariate analysis. In addition, we compared baseline characteristics and outcomes in patients with familial adenomatous polyposis (FAP) vs. sporadic ampullary lesions (SALs).

Results: Fifty-one patients (11 FAP) were included in the final analysis. Recurrence was seen in 17 patients (37.0%) among those who followed up after technical success. Complete histological (R0) resection was the only factor associated with no recurrence following EP (odds ratio [OR] 5.4, 95% confidence interval [CI] 1.4-20.8, P = 0.014). PEP was associated with delayed bleeding (OR 7.5, 95% CI 1.2-46.1, P = 0.03). In FAP vs. SAL, lesion size was smaller in FAP: 10 mm (interquartile range 6-15 mm) vs. 15 mm (12-21 mm, P = 0.03) and the en-bloc resection rate was higher (100 vs. 67.5%, P = 0.01). Although the recurrence rate was higher in FAP vs. SAL (55.6 vs. 32.4%, P = 0.2), this was not statistically significant. Rates of AEs were similar.

Conclusions: R0 resection was associated with reduced risk of recurrence whereas delayed bleeding after EP is associated with an increased risk of developing PEP. EP is safe and effective for removing ampullary lesions irrespective of lesion type.

背景和研究目的:内镜下乳头切除术(EP)是治疗壶腹部病变的有效内镜方式。本研究旨在评估因大乳头病变接受EP治疗的患者复发和不良事件(ae)的预测因素。患者和方法:这是对2006年1月至2021年12月期间因主要乳头病变接受内窥镜陷阱乳头切除术的所有患者的回顾性分析。我们评估了多个与患者和手术相关的变量,通过单变量和多变量分析来确定与ep后ae和病变复发相关的危险因素。此外,我们比较了家族性腺瘤性息肉病(FAP)和散发壶腹病变(SALs)患者的基线特征和结果。结果:51例患者(11例FAP)纳入最终分析。技术成功后随访的患者中有17例(37.0%)出现复发。完全组织学(R0)切除是EP术后无复发的唯一相关因素(优势比[OR] 5.4, 95%可信区间[CI] 1.4-20.8, P = 0.014)。PEP与迟发性出血相关(OR 7.5, 95% CI 1.2-46.1, P = 0.03)。FAP与SAL相比,FAP的病变大小更小:10 mm(四分位间距6-15 mm)比15 mm (12-21 mm, P = 0.03),整体切除率更高(100比67.5%,P = 0.01)。虽然FAP的复发率高于SAL(55.6%比32.4%,P = 0.2),但差异无统计学意义。ae的发生率相似。结论:R0切除与降低复发风险相关,而EP后延迟出血与发生PEP的风险增加相关。无论病变类型如何,EP均可安全有效地切除壶腹部病变。
{"title":"Endoscopic papillectomy of major papilla lesions: Single tertiary care center experience.","authors":"Gaurav Suryawanshi, Mohamed Abdallah, Guru Trikudanathan, Stuart K Amateau, Shawn Mallery, Martin Freeman, Nabeel Azeem","doi":"10.1055/a-2663-6291","DOIUrl":"10.1055/a-2663-6291","url":null,"abstract":"<p><strong>Background and study aims: </strong>Endoscopic papillectomy (EP) is an effective endoscopic modality for managing ampullary lesions. This study aimed to evaluate predictors for recurrence and adverse events (AEs) in patients who underwent EP for major papilla lesions.</p><p><strong>Patients and methods: </strong>This was a retrospective analysis of all patients who underwent endoscopic snare papillectomy for a major papilla lesion between January 2006 and December 2021. We assessed multiple patient- and procedure-related variables to identify risk factors related to post-EP AEs and lesion recurrence using both univariate and multivariate analysis. In addition, we compared baseline characteristics and outcomes in patients with familial adenomatous polyposis (FAP) vs. sporadic ampullary lesions (SALs).</p><p><strong>Results: </strong>Fifty-one patients (11 FAP) were included in the final analysis. Recurrence was seen in 17 patients (37.0%) among those who followed up after technical success. Complete histological (R0) resection was the only factor associated with no recurrence following EP (odds ratio [OR] 5.4, 95% confidence interval [CI] 1.4-20.8, <i>P</i> = 0.014). PEP was associated with delayed bleeding (OR 7.5, 95% CI 1.2-46.1, <i>P</i> = 0.03). In FAP vs. SAL, lesion size was smaller in FAP: 10 mm (interquartile range 6-15 mm) vs. 15 mm (12-21 mm, <i>P</i> = 0.03) and the en-bloc resection rate was higher (100 vs. 67.5%, <i>P</i> = 0.01). Although the recurrence rate was higher in FAP vs. SAL (55.6 vs. 32.4%, <i>P</i> = 0.2), this was not statistically significant. Rates of AEs were similar.</p><p><strong>Conclusions: </strong>R0 resection was associated with reduced risk of recurrence whereas delayed bleeding after EP is associated with an increased risk of developing PEP. EP is safe and effective for removing ampullary lesions irrespective of lesion type.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"13 ","pages":"a26636291"},"PeriodicalIF":2.3,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12371659/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144947249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond the ruler: Measuring what truly matters in endoscopic ultrasound-guided pancreatic cancer genomics. 超越尺子:测量内窥镜超声引导下胰腺癌基因组学中真正重要的东西。
IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-08-14 eCollection Date: 2025-01-01 DOI: 10.1055/a-2677-0505
Jinyu Wu, Wen Wang, Kuncheng Yang
{"title":"Beyond the ruler: Measuring what truly matters in endoscopic ultrasound-guided pancreatic cancer genomics.","authors":"Jinyu Wu, Wen Wang, Kuncheng Yang","doi":"10.1055/a-2677-0505","DOIUrl":"10.1055/a-2677-0505","url":null,"abstract":"","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"13 ","pages":"a26770505"},"PeriodicalIF":2.3,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12371656/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144946715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author reply to letter to the editor: Beyond the ruler: Measuring what truly matters in EUS-guided pancreatic cancer genomics. 作者给编辑的回信:超越尺子:在eus引导的胰腺癌基因组学中衡量什么才是真正重要的。
IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-08-14 eCollection Date: 2025-01-01 DOI: 10.1055/a-2677-0491
Junya Sato, Hirotoshi Ishiwatari, Kazuma Ishikawa, Hiroki Sakamoto, Masahiro Yamamura, Takuya Doi, Kazunori Takada, Yoichi Yamamoto, Masao Yoshida, Sayo Ito, Noboru Kawata, Kenichiro Imai, Kinichi Hotta, Hiroyuki Ono
{"title":"Author reply to letter to the editor: Beyond the ruler: Measuring what truly matters in EUS-guided pancreatic cancer genomics.","authors":"Junya Sato, Hirotoshi Ishiwatari, Kazuma Ishikawa, Hiroki Sakamoto, Masahiro Yamamura, Takuya Doi, Kazunori Takada, Yoichi Yamamoto, Masao Yoshida, Sayo Ito, Noboru Kawata, Kenichiro Imai, Kinichi Hotta, Hiroyuki Ono","doi":"10.1055/a-2677-0491","DOIUrl":"10.1055/a-2677-0491","url":null,"abstract":"","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"13 ","pages":"a26770491"},"PeriodicalIF":2.3,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12371645/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144946510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility and safety of endoscopic resection for duodenal gastrointestinal stromal tumors. 内镜下十二指肠胃肠道间质瘤切除术的可行性及安全性。
IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-08-07 eCollection Date: 2025-01-01 DOI: 10.1055/a-2655-1439
Shao-Bin Luo, Zu-Qiang Liu, Li Wang, Yi-Qun Zhang, Ming-Yan Cai, Quan-Lin Li, Ping-Hong Zhou

Background and study aims: Endoscopic resection for duodenal gastrointestinal stromal tumors (GISTs) is still considered a great challenge with a high risk of complications. This study aimed to evaluate effectiveness and safety of endoscopic resection for duodenal GIST.

Patients and methods: Between June 2013 and August 2024, we performed a retrospective study of patients with duodenal GISTs who underwent endoscopic resection at Zhongshan Hospital. Data on patient characteristics, clinical outcome, and follow-up were collected.

Results: A total of 73 patients with duodenal GISTs were enrolled, including 31 patients who underwent endoscopic submucosal dissection (ESD) and 42 who underwent endoscopic full-thickness resection (EFTR). Mean lesion size was 1.2 ± 0.5 cm and 1.9 ± 0.9 cm, respectively. En bloc resection rates were 96.8% and 95.2%, respectively. Rates of R0 resection were 45.2% and 42.9%, respectively. Rates of R1 resection were 54.8% and 57.1%, respectively. No patient transferred to open surgery. Postoperative adverse events included delayed bleeding (1 case), delayed perforation (1 case), delayed wall edema (2 cases), hydrothorax (1 case), and retroperitoneal infection (1 case). Mean hospital stays were 4.1 ± 2.8 days and 6.2 ± 4.9 days, respectively. No metastasis or duodenal stenosis were detected during the follow-up period (64.8 ± 43.6 months and 61.3 ± 40.2 months, respectively). Local recurrence occurred in one patient with high recurrence risk at 56 months after EFTR.

Conclusions: ESD and EFTR are safe, minimally invasive treatments for duodenal GISTs. Moreover, the EFTR technique may have advantages of completely resecting lesions originating from the deep muscularis propria layer, particularly lesions with extraluminal growth.

背景与研究目的:内镜下十二指肠胃肠道间质瘤(gist)切除术仍被认为是一项巨大的挑战,并发症风险高。本研究旨在评价内镜切除十二指肠间质瘤的有效性和安全性。患者和方法:2013年6月至2024年8月,我们对中山医院十二指肠胃肠道间质瘤内镜切除术患者进行回顾性研究。收集患者特征、临床结果和随访数据。结果:共纳入73例十二指肠gist患者,其中31例患者行内镜下粘膜剥离(ESD), 42例患者行内镜全层切除(EFTR)。平均病灶大小分别为1.2±0.5 cm和1.9±0.9 cm。整体切除率分别为96.8%和95.2%。R0切除率分别为45.2%和42.9%。R1切除率分别为54.8%和57.1%。无患者转开腹手术。术后不良事件包括迟发性出血(1例)、迟发性穿孔(1例)、迟发性壁水肿(2例)、胸水(1例)、腹膜后感染(1例)。平均住院时间分别为4.1±2.8天和6.2±4.9天。随访时间分别为64.8±43.6个月和61.3±40.2个月,未发现转移和十二指肠狭窄。1例高复发风险患者在EFTR后56个月出现局部复发。结论:ESD和EFTR是十二指肠gist安全、微创的治疗方法。此外,EFTR技术可能具有完全切除源自深层固有肌层的病变的优点,特别是腔外生长的病变。
{"title":"Feasibility and safety of endoscopic resection for duodenal gastrointestinal stromal tumors.","authors":"Shao-Bin Luo, Zu-Qiang Liu, Li Wang, Yi-Qun Zhang, Ming-Yan Cai, Quan-Lin Li, Ping-Hong Zhou","doi":"10.1055/a-2655-1439","DOIUrl":"10.1055/a-2655-1439","url":null,"abstract":"<p><strong>Background and study aims: </strong>Endoscopic resection for duodenal gastrointestinal stromal tumors (GISTs) is still considered a great challenge with a high risk of complications. This study aimed to evaluate effectiveness and safety of endoscopic resection for duodenal GIST.</p><p><strong>Patients and methods: </strong>Between June 2013 and August 2024, we performed a retrospective study of patients with duodenal GISTs who underwent endoscopic resection at Zhongshan Hospital. Data on patient characteristics, clinical outcome, and follow-up were collected.</p><p><strong>Results: </strong>A total of 73 patients with duodenal GISTs were enrolled, including 31 patients who underwent endoscopic submucosal dissection (ESD) and 42 who underwent endoscopic full-thickness resection (EFTR). Mean lesion size was 1.2 ± 0.5 cm and 1.9 ± 0.9 cm, respectively. En bloc resection rates were 96.8% and 95.2%, respectively. Rates of R0 resection were 45.2% and 42.9%, respectively. Rates of R1 resection were 54.8% and 57.1%, respectively. No patient transferred to open surgery. Postoperative adverse events included delayed bleeding (1 case), delayed perforation (1 case), delayed wall edema (2 cases), hydrothorax (1 case), and retroperitoneal infection (1 case). Mean hospital stays were 4.1 ± 2.8 days and 6.2 ± 4.9 days, respectively. No metastasis or duodenal stenosis were detected during the follow-up period (64.8 ± 43.6 months and 61.3 ± 40.2 months, respectively). Local recurrence occurred in one patient with high recurrence risk at 56 months after EFTR.</p><p><strong>Conclusions: </strong>ESD and EFTR are safe, minimally invasive treatments for duodenal GISTs. Moreover, the EFTR technique may have advantages of completely resecting lesions originating from the deep muscularis propria layer, particularly lesions with extraluminal growth.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"13 ","pages":"a26551439"},"PeriodicalIF":2.3,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12371658/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144947272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of peroral endoscopic myotomy with endoscopic fundoplication compared with POEM alone: International multicenter cohort study. 经口内窥镜下肌切开术联合内窥镜下扩底术与单独行POEM的安全性和有效性比较:国际多中心队列研究。
IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-08-07 eCollection Date: 2025-01-01 DOI: 10.1055/a-2655-6550
Michel Kahaleh, Vera Hapshy, Juan A Alcívar, Jorge Baquerizo-Burgos, Hannah Lukashok, Monica R Gaidhane, Iman Andalib, Amy Tyberg, Avik Sarkar, Haroon Shahid, Abid Allehibi, Resheed Alkhiari, Magda L Rodriguez, Carmen Bautista-Altamirano, Sarbelio Rodriguez, Maria G Porfilio, Mine Carames, Juan Carlos Carames, Amol Bapaye, Carlos Robles-Medranda

Background and study aims: Gastroesophageal reflux (GERD) can occur in a significant number of achalasia patients undergoing post-peroral endoscopic myotomy (POEM). POEM with endoscopic fundoplication (POEM-F) is a new endoscopic technique to treat post- POEM GERD. We conducted a multicenter cohort study to compare outcomes between POEM and POEM-F.

Patients and methods: We included patients who underwent POEM or POEM-F from six tertiary centers. Primary outcomes were: 1) clinical success, defined as post-procedure cessation or reduction of proton-pump inhibitors; 2) post procedure percent time pH < 4 and DeMeester score; and 3) post-procedure Eckardt scores. Secondary outcomes included adverse events, procedure time, and hospital stay duration.

Results: Sixty-four patients were included: 31 patients underwent POEM-F (mean age 51, 48% male), whereas 33 patients POEM (mean age 56, 58% male). Technical success was 100% in both groups. POEM-F patients achieved reduction/cessation in proton pump inhibitor use in 25 of 31 patients (80%); POEM patients in eight of 33 (24%) ( P ≤ 0.00001). Percent time with pH < 4 was significantly lower in the POEM-F group (2.75 +/- 2.53 vs 9.3 +/- 3.6 min, P ≤ 0.0001). Post-procedure DeMeester scores were lower (< 14.7) in POEM-F (mean 9.6) than POEM (mean 15.8) ( P ≤ 0.0011). There were three mucosal injuries in the POEM-F group and four in the POEM group. Hospital stay duration and procedure time did not differ between groups. In the POEM group, four patients required Dor fundoplication. No repeat interventions were recommended for the POEM- F group at 6-month follow-up.

Conclusions: POEM-F achieves statistically significant improvement in post- POEM GERD compared with POEM alone.

背景和研究目的:胃食管反流(GERD)可发生在相当数量的贲门失弛缓症患者经口后内镜下肌切开术(POEM)。POEM联合内镜下基底复制术(POEM- f)是一种治疗POEM术后胃食管反流的新内镜技术。我们进行了一项多中心队列研究来比较POEM和POEM- f的结果。患者和方法:我们纳入了来自六个三级中心的接受POEM或POEM- f治疗的患者。主要结局是:1)临床成功,定义为手术后质子泵抑制剂的停止或减少;2)术后pH < 4的百分比和DeMeester评分;3)术后Eckardt评分。次要结局包括不良事件、手术时间和住院时间。结果:纳入64例患者:31例患者接受了poet -f(平均年龄51岁,男性48%),而33例患者接受了POEM(平均年龄56岁,男性58%)。两组的技术成功率都是100%。31例POEM-F患者中有25例(80%)减少或停止使用质子泵抑制剂;33例患者中有8例为POEM (24%) (P≤0.00001)。POEM-F组pH < 4的时间百分比显著降低(2.75 +/- 2.53 vs 9.3 +/- 3.6 min, P≤0.0001)。POEM- f组术后DeMeester评分(平均9.6分)低于POEM组(平均15.8分)(P≤0.0011)。POEM- f组黏膜损伤3例,POEM组黏膜损伤4例。两组间住院时间和手术时间无差异。在POEM组中,有4例患者需要Dor手术。在6个月的随访中,POEM- F组不建议重复干预。结论:与单独使用POEM相比,POEM- f能显著改善术后胃食管反流。
{"title":"Safety and efficacy of peroral endoscopic myotomy with endoscopic fundoplication compared with POEM alone: International multicenter cohort study.","authors":"Michel Kahaleh, Vera Hapshy, Juan A Alcívar, Jorge Baquerizo-Burgos, Hannah Lukashok, Monica R Gaidhane, Iman Andalib, Amy Tyberg, Avik Sarkar, Haroon Shahid, Abid Allehibi, Resheed Alkhiari, Magda L Rodriguez, Carmen Bautista-Altamirano, Sarbelio Rodriguez, Maria G Porfilio, Mine Carames, Juan Carlos Carames, Amol Bapaye, Carlos Robles-Medranda","doi":"10.1055/a-2655-6550","DOIUrl":"10.1055/a-2655-6550","url":null,"abstract":"<p><strong>Background and study aims: </strong>Gastroesophageal reflux (GERD) can occur in a significant number of achalasia patients undergoing post-peroral endoscopic myotomy (POEM). POEM with endoscopic fundoplication (POEM-F) is a new endoscopic technique to treat post- POEM GERD. We conducted a multicenter cohort study to compare outcomes between POEM and POEM-F.</p><p><strong>Patients and methods: </strong>We included patients who underwent POEM or POEM-F from six tertiary centers. Primary outcomes were: 1) clinical success, defined as post-procedure cessation or reduction of proton-pump inhibitors; 2) post procedure percent time pH < 4 and DeMeester score; and 3) post-procedure Eckardt scores. Secondary outcomes included adverse events, procedure time, and hospital stay duration.</p><p><strong>Results: </strong>Sixty-four patients were included: 31 patients underwent POEM-F (mean age 51, 48% male), whereas 33 patients POEM (mean age 56, 58% male). Technical success was 100% in both groups. POEM-F patients achieved reduction/cessation in proton pump inhibitor use in 25 of 31 patients (80%); POEM patients in eight of 33 (24%) ( <i>P</i> ≤ 0.00001). Percent time with pH < 4 was significantly lower in the POEM-F group (2.75 +/- 2.53 vs 9.3 +/- 3.6 min, <i>P</i> ≤ 0.0001). Post-procedure DeMeester scores were lower (< 14.7) in POEM-F (mean 9.6) than POEM (mean 15.8) ( <i>P</i> ≤ 0.0011). There were three mucosal injuries in the POEM-F group and four in the POEM group. Hospital stay duration and procedure time did not differ between groups. In the POEM group, four patients required Dor fundoplication. No repeat interventions were recommended for the POEM- F group at 6-month follow-up.</p><p><strong>Conclusions: </strong>POEM-F achieves statistically significant improvement in post- POEM GERD compared with POEM alone.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"13 ","pages":"a26556550"},"PeriodicalIF":2.3,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12371642/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144947327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Direct visualization endoscopic retrograde appendicitis therapy versus laparoscopic appendectomy for management of acute uncomplicated appendicitis. 直接可视化内镜逆行阑尾炎治疗与腹腔镜阑尾切除术治疗急性无并发症阑尾炎的比较。
IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-08-07 eCollection Date: 2025-01-01 DOI: 10.1055/a-2638-6177
Jun-Yu Pan, Hui-Xin Zhi, Jie-Li Chen, Hao-Xin Chen, De-Feng Li, Jun Yao, Li-Sheng Wang

Background and study aims: Direct visualization endoscopic retrograde appendicitis therapy (ERAT), an advanced technique building upon conventional ERAT, represents a novel endoscopic approach for managing acute uncomplicated appendicitis. This study aimed to assess clinical efficacy and safety of employing cholangioscope-guided endoscopic intervention as a therapeutic approach.

Patients and methods: A retrospective analysis was conducted on 656 patients presenting with suspected acute appendicitis between February 2024 and November 2024. To minimize baseline differences, propensity score matching was applied, resulting in a final study population of 34 patients undergoing direct visualization ERAT and 68 patients treated with laparoscopic appendectomy (LA). Key outcome measures included technical and clinical success rates, operative time, time to postoperative pain resolution, length of hospital stay, recurrence rate, incidence of adverse events (AEs), and overall patient satisfaction.

Results: The technical success rate was 97.06% (33/34) in the ERAT group and 100% in the LA group ( P = 0.333), while clinical success was achieved in 94.12% (32/34) of ERAT cases compared with 100% in the LA cohort ( P = 0.109). Notably, ERAT was associated with a significantly shorter operative time (37 vs 50 minutes; P < 0.001) and more rapid postoperative pain relief ( P = 0.001), with a greater proportion of patients reporting complete symptom resolution within 2 days of the procedure. There were no significant differences between the two groups in terms of AEs, length of hospital stay, or patient satisfaction. During follow-up, a recurrence of appendicitis was observed in one ERAT patient (2.94%, 1/34).

Conclusions: Direct visualization ERAT demonstrated high feasibility and effectiveness as a diagnostic and therapeutic modality for acute uncomplicated appendicitis, offering a promising alternative to conventional approaches.

背景与研究目的:内镜逆行性阑尾炎直接可视化治疗(ERAT)是在传统内镜逆行性阑尾炎治疗基础上发展起来的一种先进技术,是治疗急性无并发症阑尾炎的一种新的内镜方法。本研究旨在评估胆道镜引导下的内镜干预作为治疗方法的临床疗效和安全性。患者与方法:回顾性分析2024年2月至11月656例疑似急性阑尾炎患者的临床资料。为了尽量减少基线差异,采用倾向评分匹配,最终研究人群为34例接受直接可视化ERAT的患者和68例接受腹腔镜阑尾切除术(LA)的患者。主要结局指标包括技术和临床成功率、手术时间、术后疼痛缓解时间、住院时间、复发率、不良事件发生率(ae)和患者总体满意度。结果:ERAT组的技术成功率为97.06% (33/34),LA组为100% (P = 0.333); ERAT组的临床成功率为94.12% (32/34),LA组为100% (P = 0.109)。值得注意的是,ERAT与更短的手术时间(37 vs 50分钟;P < 0.001)和更快的术后疼痛缓解(P = 0.001)相关,更大比例的患者报告在手术后2天内症状完全缓解。两组在ae、住院时间或患者满意度方面无显著差异。随访期间,1例ERAT患者阑尾炎复发(2.94%,1/34)。结论:直接可视化ERAT作为急性无并发症阑尾炎的诊断和治疗方式具有很高的可行性和有效性,是传统方法的一种有希望的替代方法。
{"title":"Direct visualization endoscopic retrograde appendicitis therapy versus laparoscopic appendectomy for management of acute uncomplicated appendicitis.","authors":"Jun-Yu Pan, Hui-Xin Zhi, Jie-Li Chen, Hao-Xin Chen, De-Feng Li, Jun Yao, Li-Sheng Wang","doi":"10.1055/a-2638-6177","DOIUrl":"10.1055/a-2638-6177","url":null,"abstract":"<p><strong>Background and study aims: </strong>Direct visualization endoscopic retrograde appendicitis therapy (ERAT), an advanced technique building upon conventional ERAT, represents a novel endoscopic approach for managing acute uncomplicated appendicitis. This study aimed to assess clinical efficacy and safety of employing cholangioscope-guided endoscopic intervention as a therapeutic approach.</p><p><strong>Patients and methods: </strong>A retrospective analysis was conducted on 656 patients presenting with suspected acute appendicitis between February 2024 and November 2024. To minimize baseline differences, propensity score matching was applied, resulting in a final study population of 34 patients undergoing direct visualization ERAT and 68 patients treated with laparoscopic appendectomy (LA). Key outcome measures included technical and clinical success rates, operative time, time to postoperative pain resolution, length of hospital stay, recurrence rate, incidence of adverse events (AEs), and overall patient satisfaction.</p><p><strong>Results: </strong>The technical success rate was 97.06% (33/34) in the ERAT group and 100% in the LA group ( <i>P</i> = 0.333), while clinical success was achieved in 94.12% (32/34) of ERAT cases compared with 100% in the LA cohort ( <i>P</i> = 0.109). Notably, ERAT was associated with a significantly shorter operative time (37 vs 50 minutes; <i>P</i> < 0.001) and more rapid postoperative pain relief ( <i>P</i> = 0.001), with a greater proportion of patients reporting complete symptom resolution within 2 days of the procedure. There were no significant differences between the two groups in terms of AEs, length of hospital stay, or patient satisfaction. During follow-up, a recurrence of appendicitis was observed in one ERAT patient (2.94%, 1/34).</p><p><strong>Conclusions: </strong>Direct visualization ERAT demonstrated high feasibility and effectiveness as a diagnostic and therapeutic modality for acute uncomplicated appendicitis, offering a promising alternative to conventional approaches.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"13 ","pages":"a26386177"},"PeriodicalIF":2.3,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12371657/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144947111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Capnography monitoring reduces incidence of hypoxia in older patients undergoing gastrointestinal endoscopy under propofol sedation. 在异丙酚镇静下进行胃肠内窥镜检查的老年患者中,血管造影监测可减少缺氧的发生率。
IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-08-07 eCollection Date: 2025-01-01 DOI: 10.1055/a-2663-6372
Qiuyue Lian, Jianbo Wu, Jie Zhang, Yizhe Zhang, Xiangyang Cheng, Xiaomei Yang, Renlong Zhou, Yue Chen, Weiwei Ding, Guangzhi Wang, Weifeng Yu, Jiaqiang Zhang, Diansan Su

Background and study aims: Whether routine capnography monitoring during gastrointestinal endoscopy sedation can reduce occurrence of hypoxia is controversial. Older patients are more prone to hypoxia. This study aimed to determine the effect of additional capnography monitoring on incidence of hypoxia in older patients undergoing gastrointestinal endoscopy under propofol sedation.

Patients and methods: A multicenter, randomized, single-blind, two-arm, parallel-group, controlled with an active comparator, interventional superiority clinical trial was performed at three teaching hospitals in China between September 1, 2021, and September 1, 2022. This study compared additional capnography monitoring (intervention group) and standard monitoring (control group) among older patients (aged 65-79 years) undergoing gastrointestinal endoscopy under propofol sedation. The primary outcome was incidence of hypoxia (75%-89% for < 60s). Secondary outcomes were incidence of subclinical hypoxia (90%-94%), incidence of severe hypoxia (< 75% for any duration or 75%-89% for ≥ 60s), and other adverse events (AEs).

Results: Data from 1777 participants (888 intervention, 889 control group) were analyzed. Additional capnography monitoring reduced incidence of hypoxia in older patients from 19% to 12% ( P < 0.001). Incidence of subclinical hypoxia in the additional capnographymonitoring group was 23% and in the standard monitoring group was 15% ( P < 0.001). There was no significant difference in incidence of severe hypoxia ( P = 0.070) and other AEs between the two groups ( P = 0.374).

Conclusions: Additional capnography monitoring during gastrointestinal endoscopy for older patients who were sedated with propofol reduces incidence of hypoxia.

背景与研究目的:胃肠内镜镇静期间的常规血管造影监测是否能减少缺氧的发生尚存争议。老年患者更容易出现缺氧。本研究旨在确定在异丙酚镇静下接受胃肠内镜检查的老年患者中,额外的造影监测对缺氧发生率的影响。患者和方法:于2021年9月1日至2022年9月1日在中国三家教学医院进行了一项多中心、随机、单盲、双臂、平行组、主动对照、介入优势临床试验。本研究比较了在异丙酚镇静下接受胃肠内窥镜检查的老年患者(65-79岁)额外的造影监测(干预组)和标准监测(对照组)。主要终点为缺氧发生率(< 60岁患者75%-89%)。次要结局是亚临床缺氧发生率(90%-94%)、严重缺氧发生率(任何持续时间< 75%或≥60s 75%-89%)和其他不良事件(ae)。结果:分析了1777名参与者(干预组888人,对照组889人)的数据。额外的血管造影监测使老年患者缺氧发生率从19%降至12% (P < 0.001)。附加血糖监测组亚临床缺氧发生率为23%,标准监测组为15% (P < 0.001)。两组患者严重缺氧发生率(P = 0.070)及其他ae发生率(P = 0.374)差异无统计学意义。结论:使用异丙酚镇静的老年患者在胃肠内镜检查期间进行额外的血管造影监测可减少缺氧的发生率。
{"title":"Capnography monitoring reduces incidence of hypoxia in older patients undergoing gastrointestinal endoscopy under propofol sedation.","authors":"Qiuyue Lian, Jianbo Wu, Jie Zhang, Yizhe Zhang, Xiangyang Cheng, Xiaomei Yang, Renlong Zhou, Yue Chen, Weiwei Ding, Guangzhi Wang, Weifeng Yu, Jiaqiang Zhang, Diansan Su","doi":"10.1055/a-2663-6372","DOIUrl":"10.1055/a-2663-6372","url":null,"abstract":"<p><strong>Background and study aims: </strong>Whether routine capnography monitoring during gastrointestinal endoscopy sedation can reduce occurrence of hypoxia is controversial. Older patients are more prone to hypoxia. This study aimed to determine the effect of additional capnography monitoring on incidence of hypoxia in older patients undergoing gastrointestinal endoscopy under propofol sedation.</p><p><strong>Patients and methods: </strong>A multicenter, randomized, single-blind, two-arm, parallel-group, controlled with an active comparator, interventional superiority clinical trial was performed at three teaching hospitals in China between September 1, 2021, and September 1, 2022. This study compared additional capnography monitoring (intervention group) and standard monitoring (control group) among older patients (aged 65-79 years) undergoing gastrointestinal endoscopy under propofol sedation. The primary outcome was incidence of hypoxia (75%-89% for < 60s). Secondary outcomes were incidence of subclinical hypoxia (90%-94%), incidence of severe hypoxia (< 75% for any duration or 75%-89% for ≥ 60s), and other adverse events (AEs).</p><p><strong>Results: </strong>Data from 1777 participants (888 intervention, 889 control group) were analyzed. Additional capnography monitoring reduced incidence of hypoxia in older patients from 19% to 12% ( <i>P</i> < 0.001). Incidence of subclinical hypoxia in the additional capnographymonitoring group was 23% and in the standard monitoring group was 15% ( <i>P</i> < 0.001). There was no significant difference in incidence of severe hypoxia ( <i>P</i> = 0.070) and other AEs between the two groups ( <i>P</i> = 0.374).</p><p><strong>Conclusions: </strong>Additional capnography monitoring during gastrointestinal endoscopy for older patients who were sedated with propofol reduces incidence of hypoxia.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"13 ","pages":"a26636372"},"PeriodicalIF":2.3,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12371663/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144946693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GastroGPT: Development and controlled testing of a proof-of-concept customized clinical language model. GastroGPT:开发和控制概念验证定制临床语言模型的测试。
IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-08-06 eCollection Date: 2025-01-01 DOI: 10.1055/a-2637-2163
Cem Simsek, Mete Ucdal, Enrique de-Madaria, Alanna Ebigbo, Petr Vanek, Omar Elshaarawy, Theodor Alexandru Voiosu, Giulio Antonelli, Román Turró, Javier P Gisbert, Olga P Nyssen, Cesare Hassan, Helmut Messmann, Rajiv Jalan

Background and study aims: Current general-purpose artificial intelligence (AI) large language models (LLMs) demonstrate limited efficacy in clinical medicine, often constrained to question-answering, documentation, and literature summarization roles. We developed GastroGPT, a proof-of-concept specialty-specific, multi-task, clinical LLM, and evaluated its performance against leading general-purpose LLMs across key gastroenterology tasks and diverse case scenarios.

Methods: In this structured analysis, GastroGPT was compared with three state-of-the-art general-purpose LLMs (LLM-A: GPT-4, LLM-B: Bard, LLM-C: Claude). Models were assessed on seven clinical tasks and overall performance across 10 simulated gastroenterology cases varying in complexity, frequency, and patient demographics. Standardized prompts facilitated structured comparisons. A blinded expert panel rated model outputs per task on a 10-point Likert scale, judging clinical utility. Comprehensive statistical analyses were conducted.

Results: A total of 2,240 expert ratings were obtained. GastroGPT achieved significantly higher mean overall scores (8.1 ± 1.8) compared with GPT-4 (5.2 ± 3.0), Bard (5.7 ± 3.3), and Claude (7.0 ± 2.7) (all P < 0.001). It outperformed comparators in six of seven tasks ( P < 0.05), except follow-up planning. GastroGPT demonstrated superior score consistency (variance 34.95) versus general models (97.4-260.35) ( P < 0.001). Its performance remained consistent across case complexities and frequencies, unlike the comparators ( P < 0.001). Multivariate analysis revealed that model type significantly predicted performance ( P < 0.001).

Conclusions: This study pioneered development and comparison of a specialty-specific, clinically-oriented AI model to general-purpose LLMs. GastroGPT demonstrated superior utility overall and on key gastroenterology tasks, highlighting the potential for tailored, task-focused AI models in medicine.

背景和研究目的:目前的通用人工智能(AI)大语言模型(llm)在临床医学中的功效有限,通常局限于问答、文档和文献总结的角色。我们开发了胃肠法学硕士(GastroGPT),这是一种概念验证型的多任务临床法学硕士,并对其在关键胃肠病学任务和不同病例情况下与领先的通用法学硕士的表现进行了评估。方法:在这个结构化分析中,将GastroGPT与三种最先进的通用llm (LLM-A: GPT-4, LLM-B: Bard, LLM-C: Claude)进行比较。模型在7项临床任务和10个模拟胃肠病学病例的总体表现上进行了评估,这些病例在复杂性、频率和患者人口统计学上有所不同。标准化的提示有助于结构化的比较。一个盲法专家小组对每项任务的模型输出进行10分李克特评分,以判断临床效用。进行综合统计分析。结果:共获得专家评分2240份。与GPT-4评分(5.2±3.0)、Bard评分(5.7±3.3)和Claude评分(7.0±2.7)相比,GastroGPT评分(8.1±1.8)显著高于GPT-4评分(5.2±3.0)、Bard评分(5.7±3.3)和Claude评分(7.0±2.7)(均P < 0.001)。除随访计划外,7项任务中有6项优于比较国家(P < 0.05)。与一般模型(97.4-260.35)相比,GastroGPT表现出更好的评分一致性(方差34.95)(P < 0.001)。不同于比较器(P < 0.001),它的性能在案件复杂性和频率上保持一致。多变量分析显示,模型类型显著预测绩效(P < 0.001)。结论:这项研究开创了一种专门的、面向临床的人工智能模型与通用法学硕士的开发和比较。GastroGPT在胃肠病学的关键任务中表现出了卓越的实用性,突出了医学领域量身定制的、以任务为中心的人工智能模型的潜力。
{"title":"GastroGPT: Development and controlled testing of a proof-of-concept customized clinical language model.","authors":"Cem Simsek, Mete Ucdal, Enrique de-Madaria, Alanna Ebigbo, Petr Vanek, Omar Elshaarawy, Theodor Alexandru Voiosu, Giulio Antonelli, Román Turró, Javier P Gisbert, Olga P Nyssen, Cesare Hassan, Helmut Messmann, Rajiv Jalan","doi":"10.1055/a-2637-2163","DOIUrl":"10.1055/a-2637-2163","url":null,"abstract":"<p><strong>Background and study aims: </strong>Current general-purpose artificial intelligence (AI) large language models (LLMs) demonstrate limited efficacy in clinical medicine, often constrained to question-answering, documentation, and literature summarization roles. We developed GastroGPT, a proof-of-concept specialty-specific, multi-task, clinical LLM, and evaluated its performance against leading general-purpose LLMs across key gastroenterology tasks and diverse case scenarios.</p><p><strong>Methods: </strong>In this structured analysis, GastroGPT was compared with three state-of-the-art general-purpose LLMs (LLM-A: GPT-4, LLM-B: Bard, LLM-C: Claude). Models were assessed on seven clinical tasks and overall performance across 10 simulated gastroenterology cases varying in complexity, frequency, and patient demographics. Standardized prompts facilitated structured comparisons. A blinded expert panel rated model outputs per task on a 10-point Likert scale, judging clinical utility. Comprehensive statistical analyses were conducted.</p><p><strong>Results: </strong>A total of 2,240 expert ratings were obtained. GastroGPT achieved significantly higher mean overall scores (8.1 ± 1.8) compared with GPT-4 (5.2 ± 3.0), Bard (5.7 ± 3.3), and Claude (7.0 ± 2.7) (all <i>P</i> < 0.001). It outperformed comparators in six of seven tasks ( <i>P</i> < 0.05), except follow-up planning. GastroGPT demonstrated superior score consistency (variance 34.95) versus general models (97.4-260.35) ( <i>P</i> < 0.001). Its performance remained consistent across case complexities and frequencies, unlike the comparators ( <i>P</i> < 0.001). Multivariate analysis revealed that model type significantly predicted performance ( <i>P</i> < 0.001).</p><p><strong>Conclusions: </strong>This study pioneered development and comparison of a specialty-specific, clinically-oriented AI model to general-purpose LLMs. GastroGPT demonstrated superior utility overall and on key gastroenterology tasks, highlighting the potential for tailored, task-focused AI models in medicine.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"13 ","pages":"a26372163"},"PeriodicalIF":2.3,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12371664/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144947356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Please stay seated - the specialist AI will see you shortly. 请坐好,人工智能专家马上就来。
IF 2.3 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-08-06 eCollection Date: 2025-01-01 DOI: 10.1055/a-2655-6281
Keith Siau
{"title":"Please stay seated - the specialist AI will see you shortly.","authors":"Keith Siau","doi":"10.1055/a-2655-6281","DOIUrl":"10.1055/a-2655-6281","url":null,"abstract":"","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"13 ","pages":"a26556281"},"PeriodicalIF":2.3,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12371651/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144947302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Endoscopy International Open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1